BMC Gastroenterol
- WEI S, Xie Q, Liao G, Chen H, et al
Patients with chronic hepatitis B who have persistently normal alanine
aminotransferase or aged < 30 years may exhibit significant histologic damage.
BMC Gastroenterol. 2024;24:120.
Clin Infect Dis
- BERTUMEN JB, Pascopella L, Han E, Glenn-Finer R, et al
Epidemiology and Treatment Outcomes of Tuberculosis with Chronic Hepatitis B
Infection-California, 2016-2020.
Clin Infect Dis. 2024 Mar 26:ciae169. doi: 10.1093.
J Hepatol
- HIN-MAN LEUNG R, Wan-Hin Hui R, Mak LY, Mao X, et al
ALT to qHBsAg ratio predicts long-term HBsAg seroclearance after entecavir
cessation in Chinese patients with chronic hepatitis B.
J Hepatol. 2024 Mar 23:S0168-8278(24)00204-6. doi: 10.1016/j.jhep.2024.
- PASTA A, Pieri G, Plaz Torres MC, Trevisani F, et al
Hepatocellular carcinoma in patients with Autoimmune Hepatitis.
J Hepatol. 2024 Mar 23:S0168-8278(24)00208-3. doi: 10.1016/j.jhep.2024.
- PLAGIANNAKOS CG, Hirschfield GM, Lytvyak E, Roberts SB, et al
Treatment response and clinical event-free survival in autoimmune hepatitis: a
Canadian multicentre cohort study.
J Hepatol. 2024 Mar 23:S0168-8278(24)00205-8. doi: 10.1016/j.jhep.2024.
- SEMMLER G, Alonso Lopez S, Pons M, Lens S, et al
Post-treatment LSM rather than change during treatment predicts decompensation in
patients with cACLD after HCV cure.
J Hepatol. 2024 Mar 21:S0168-8278(24)00198-3. doi: 10.1016/j.jhep.2024.
- BISWAS S, Shalimar
Mycophenolate Mofetil in Autoimmune Hepatitis: Are We Ready for Primetime?
J Hepatol. 2024 Mar 20:S0168-8278(24)00201-0. doi: 10.1016/j.jhep.2024.
J Infect Dis
- WHITTAKER R, Midtbo JE, Klovstad H
Monitoring progress towards the elimination of hepatitis C as a public health
threat in Norway: a modelling study among people who inject drugs and immigrants.
J Infect Dis. 2024 Mar 27:jiae147. doi: 10.1093.
J Med Virol
- ZHANG H, Li M, Liu H, Dong Y, et al
Juveniles, young adults, and infants with hepatitis B virus infection: A genomic
study.
J Med Virol. 2024;96:e29530.
J Viral Hepat
- GUPTA N, Swindells S, Scarsi KK, Furl R, et al
Preferences and feasibility of long-acting technologies for treatment of
hepatitis C virus in low- and middle-income countries: A survey of providers and
policymakers.
J Viral Hepat. 2024 Mar 28. doi: 10.1111/jvh.13921.
J Virol
- SHENG Y, Deng Y, Li X, Ji P, et al
Hepatitis E virus ORF3 protein hijacking thioredoxin domain-containing protein 5
(TXNDC5) for its stability to promote viral particle release.
J Virol. 2024 Mar 29:e0164923. doi: 10.1128/jvi.01649.
PLoS Comput Biol
- KITAGAWA K, Kim KS, Iwamoto M, Hayashi S, et al
Multiscale modeling of HBV infection integrating intra- and intercellular viral
propagation to analyze extracellular viral markers.
PLoS Comput Biol. 2024;20:e1011238.
PLoS One
- VECHI HT, Bay MB, Freitas CHS, Sant'anna JGFC, et al
Factors associated with hepatitis A susceptibility among men who have sex with
men using HIV pre-exposure prophylaxis in Northeastern Brazil: A cross-sectional
study.
PLoS One. 2024;19:e0301397.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016